GW 1929 is an orally active peroxisome proliferator-activated receptor-γ ( PPARγ ) agonist with a pK i of 8.84 for human PPAR-γ , and pEC 50 s of 8.56 and 8.27 for human PPAR-γ and murine PPAR-γ , respectively. GW 1929 (hydrochloride) has antidiabetic efficacy and neuroprotective potential .